
TL;DR: A 2026 study in Health Science Reports found that metoclopramide and several antipsychotics were strongly overrepresented in FDA adverse-event reports for drug-induced dystonia, with many reported cases appearing within the first month after drug initia…
Read article ↗
TL;DR: A 2026 case study in Neurological Sciences described 2 Tourette syndrome patients who developed oculogyric crisis, a sustained upward eye-rolling dystonia, after aripiprazole was increased to 20-30 mg/day, with both cases resolving after dose reduction.…
Read article ↗
A new study published in Pharmazie takes a close look at adverse event reports related to drug-induced weight gain submitted to the FDA over the past 10 years. The retrospective analysis provides insight into the drugs most commonly associated with weight gain…
Read article ↗